January 2023 FDA Recall Drug by Amerisource Health Services Llc
D-0436-2023 - Failed Dissolution Specification

This Class II drug recall was voluntarily initiated by Amerisource Health Services Llc on January 27, 2023 for the product Drug. The FDA reported the reason for recall as failed dissolution specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0436-2023

Reason for Recall
Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.
Initiated
01-27-2023
Reported
03-15-2023
Quantity
422 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amerisource Health Services LLC
Nationwide in the USA
Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-493-01; NDC Unit Dose: 60687-493-11.

Batch or Lot Expiration Information

Lot# Lot 1009065, Exp 12/31/2023